Fludeoxyglucose 18F Injection is a radiopharmaceutical agent primarily utilized as a positron emission tomography (PET) tracer in nuclear medicine. By tracking glucose metabolism, this compound assists… Read more
Fludeoxyglucose 18F Injection is a radiopharmaceutical agent primarily utilized as a positron emission tomography (PET) tracer in nuclear medicine. By tracking glucose metabolism, this compound assists in diagnosing various medical conditions, including cancer, heart disease, and neurological disorders. This category provides access to critical reference standards for the active pharmaceutical ingredient, alongside related impurities such as chlorinated analogues and cryptand-related compounds. Pharmaceutical laboratories rely on these high-quality materials for impurity profiling, method validation, and rigorous quality control testing. Access to these standardized compounds ensures that analytical procedures are accurate and consistent, supporting the precise evaluation required for diagnostic radiopharmaceuticals. These materials are essential for maintaining regulatory compliance and ensuring the safety and efficacy of diagnostic scans in clinical environments.
![Chemical structure of Fludeoxyglucose Related Compound A (4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane) (1272918)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F23978-09-8-Fludeoxyglucose-Related-Compound-A-4713162124-hexaoxa-110-diazabicyclo8.8.8hexacosane-1272918.png&w=3840&q=75)